Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 5, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-112919.pdf 0001209191-16-112919.rtf 0001209191-16-112919.xls View HTML
March 18, 2016	3	Initial filing by director officer or owner of more than ten percent.	0001209191-16-109450.pdf 0001209191-16-109450.rtf 0001209191-16-109450.xls View HTML
March 14, 2016	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-16-014700.pdf 0001564590-16-014700.rtf 0001564590-16-014700.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 9, 2016	8-K	Report of unscheduled material events or corporate event	0001193125-16-497947.pdf 0001193125-16-497947.rtf 0001193125-16-497947.xls View HTML
February 24, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-101847.pdf 0001209191-16-101847.rtf 0001209191-16-101847.xls View HTML
February 24, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-101855.pdf 0001209191-16-101855.rtf 0001209191-16-101855.xls View HTML
February 24, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-101851.pdf 0001209191-16-101851.rtf 0001209191-16-101851.xls View HTML
February 24, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-101849.pdf 0001209191-16-101849.rtf 0001209191-16-101849.xls View HTML
February 12, 2016	SC 13G/A	An amendment to the SC 13G filing	0000897069-16-000698.pdf 0000897069-16-000698.rtf 0000897069-16-000698.xls View HTML
February 12, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000315066-16-004791.pdf 0000315066-16-004791.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax